美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Kairos Pharma, Ltd.

0.6310

-0.0001-0.02%

成交量：2.94萬

成交額：1.83萬

市值：1,313.83萬

市盈率：-2.06

高：0.6310

開：0.6310

低：0.6121

收：0.6311

52周最高：2.11

52周最低：0.4000

股本：2,082.14萬

流通股本：155.00萬

量比：0.48

換手率：1.90%

股息：- -

股息率：- -

每股收益(TTM):-0.3056

每股收益(LYR):-0.2292

淨資產收益率：-92.07%

總資產收益率：-53.59%

市淨率：1.71

市盈率(LYR):-2.75

資料載入中...

總覽公司新聞資訊公告

Kairos Pharma簽署具有約束力的戰略資產收購協議，獲得Orbimed及Torrey Pines投資支持的Celyn Therapeutics旗下Cl-273全球獨家授權

Kairos Pharma, Ltd.股價上漲13.85% 市值漲206.42萬美元

Uniqure N.V.股價重挫16.96% 市值漲5422.18萬美元

Kairos製藥有限公司簽署條款書，擬戰略性收購Celyn Therapeutics兩項臨床腫瘤資產

Kairos Pharma, Ltd.盤中異動快速上漲5.41%

Kairos Pharma, Ltd.盤中異動早盤股價大跌5.06%報0.881美元

Kairos Pharma將在2025年ESMO大會上公布前列腺癌二期試驗積極的安全性和療效數據

Kairos Pharma宣佈Env105治療晚期前列腺癌2期試驗積極中期療效分析結果，中位無進展生存期超過一年

Kairos Pharma, Ltd.宣佈舉辦虛擬專家活動分享Env105治療晚期前列腺癌中期療效數據見解

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/KAPA/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KAPA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","market":"US","secType":"STK","nameCN":"Kairos Pharma, Ltd.","latestPrice":0.631,"timestamp":1773154826949,"preClose":0.6311,"halted":0,"volume":29399,"delay":0,"changeRate":-0.00015845349389952303,"floatShares":1550000,"shares":20821353,"eps":-0.30563,"marketStatus":"交易中","change":-0.0001,"latestTime":"03-10 11:00:49 EDT","open":0.631,"high":0.631,"low":0.6121,"amount":18281.1390114,"amplitude":0.029948,"askPrice":0.6466,"askSize":100,"bidPrice":0.62,"bidSize":19,"shortable":3,"etf":0,"ttmEps":-0.30563,"tradingStatus":2,"nextMarketStatus":{"tag":"盤後交易","tradingStatus":3,"beginTime":1773172800000},"marketStatusCode":2,"adr":0,"listingDate":1717992000000,"exchange":"AMEX","adjPreClose":0.6311,"preHourTrading":{"tag":"盘前","latestPrice":0.6311,"preClose":0.6311,"latestTime":"09:26 EDT","volume":1579,"amount":973.1249732599999,"timestamp":1773149213145,"change":0,"changeRate":0,"amplitude":0.044842},"postHourTrading":{"tag":"盘后","latestPrice":0.634,"preClose":0.6311,"latestTime":"19:43 EDT","volume":7720,"amount":4831.3386,"timestamp":1773099811938,"change":0.0029,"changeRate":0.004595,"amplitude":0.033117},"volumeRatio":0.475717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KAPA\",,,,,undefined,":{"symbol":"KAPA","floatShares":1550000,"roa":"-53.59%","roe":"-92.07%","lyrEps":-0.229208,"volumeRatio":0.475717,"shares":20821353,"dividePrice":0,"high":0.631,"amplitude":0.029948,"preClose":0.6311,"low":0.6121,"week52Low":0.4,"pbRate":"1.71","week52High":2.11,"institutionHeld":0,"latestPrice":0.631,"committee":-0.680672,"eps":-0.30563,"divideRate":0,"volume":29399,"delay":0,"ttmEps":-0.30563,"open":0.631,"prevYearClose":0.71,"prevWeekClose":0.6299,"prevMonthClose":0.6055,"prevQuarterClose":0.71,"fiveDayClose":0.6242,"twentyDayClose":0.64,"sixtyDayClose":0.84},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KAPA\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KAPA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KAPA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":3,"updateTime":1743825600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/KAPA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"KAPA","date":"2026-03-06","current":-2.064915,"percent":0.915761,"low":-25.607053,"twenty":-7.424045,"median":-5.019718,"eighty":-3.093003,"high":-2.140651,"avg":-5.545756,"sd":2.928186,"marketCap":13658807},"quantilePoints":[{"date":"2024-09-13","current":-25.607053,"twenty":-25.607053,"median":-25.607053,"eighty":-25.607053,"marketCap":51367748},{"date":"2024-09-20","current":-14.59602,"twenty":-25.607053,"median":-16.196461,"eighty":-14.724055,"marketCap":29279616},{"date":"2024-09-27","current":-10.594918,"twenty":-16.644584,"median":-14.59602,"eighty":-12.803526,"marketCap":21253405},{"date":"2024-10-04","current":-8.706398,"twenty":-15.748337,"median":-12.835535,"eighty":-9.858715,"marketCap":17465034},{"date":"2024-10-11","current":-9.410592,"twenty":-14.724055,"median":-10.594918,"eighty":-8.706398,"marketCap":18877647},{"date":"2024-10-18","current":-9.410592,"twenty":-14.59602,"median":-9.890724,"eighty":-9.026486,"marketCap":18877647},{"date":"2024-10-25","current":-9.602645,"twenty":-14.019861,"median":-9.73068,"eighty":-9.026486,"marketCap":19262905},{"date":"2024-10-31","current":-8.64238,"twenty":-13.098007,"median":-9.602645,"eighty":-8.947104,"marketCap":17336614},{"date":"2024-11-08","current":-8.770415,"twenty":-12.81633,"median":-9.464686,"eighty":-8.64238,"marketCap":17593453},{"date":"2024-11-15","current":-13.158824,"twenty":-13.152678,"median":-9.474609,"eighty":-8.64238,"marketCap":26396601},{"date":"2024-11-22","current":-7.030345,"twenty":-12.924264,"median":-9.410592,"eighty":-8.578362,"marketCap":19270177},{"date":"2024-11-29","current":-7.217821,"twenty":-12.829133,"median":-9.282556,"eighty":-8.469532,"marketCap":19784048},{"date":"2024-12-06","current":-6.608525,"twenty":-12.265778,"median":-9.026486,"eighty":-7.967725,"marketCap":18113966},{"date":"2024-12-13","current":-8.061463,"twenty":-11.119862,"median":-8.738406,"eighty":-7.667763,"marketCap":22096470},{"date":"2024-12-20","current":-7.920856,"twenty":-10.268428,"median":-8.706398,"eighty":-7.780249,"marketCap":21711066},{"date":"2024-12-27","current":-7.827118,"twenty":-9.999554,"median":-8.64238,"eighty":-7.780249,"marketCap":21454130},{"date":"2025-01-03","current":-7.170953,"twenty":-9.909929,"median":-8.578362,"eighty":-7.46154,"marketCap":19655581},{"date":"2025-01-10","current":-4.827504,"twenty":-9.858715,"median":-8.578362,"eighty":-7.311559,"marketCap":13232188},{"date":"2025-01-17","current":-8.295808,"twenty":-9.858715,"median":-8.530349,"eighty":-7.261949,"marketCap":22738809},{"date":"2025-01-24","current":-7.311559,"twenty":-9.756287,"median":-8.373067,"eighty":-7.264142,"marketCap":20040984},{"date":"2025-01-31","current":-6.936607,"twenty":-9.73068,"median":-8.108332,"eighty":-7.170953,"marketCap":19013241},{"date":"2025-02-07","current":-6.749132,"twenty":-9.628252,"median":-8.036517,"eighty":-7.161579,"marketCap":18499370},{"date":"2025-02-14","current":-6.796001,"twenty":-9.602645,"median":-7.967725,"eighty":-7.030345,"marketCap":18627838},{"date":"2025-02-21","current":-6.233573,"twenty":-9.526207,"median":-7.967725,"eighty":-7.030345,"marketCap":17086224},{"date":"2025-02-28","current":-5.671145,"twenty":-9.474865,"median":-7.897422,"eighty":-6.869431,"marketCap":15544609},{"date":"2025-03-07","current":-5.198227,"twenty":-9.462702,"median":-7.803684,"eighty":-6.730384,"marketCap":14248340},{"date":"2025-03-14","current":-4.773372,"twenty":-9.428261,"median":-7.780249,"eighty":-6.44917,"marketCap":13083812},{"date":"2025-03-21","current":-4.898329,"twenty":-9.410592,"median":-7.639642,"eighty":-6.289816,"marketCap":13426320},{"date":"2025-03-28","current":-4.848346,"twenty":-9.33377,"median":-7.452166,"eighty":-6.092966,"marketCap":13289317},{"date":"2025-04-04","current":-4.698397,"twenty":-9.282556,"median":-7.358428,"eighty":-5.577408,"marketCap":12878307},{"date":"2025-04-11","current":-4.948312,"twenty":-9.244146,"median":-7.311559,"eighty":-5.297393,"marketCap":13563323},{"date":"2025-04-17","current":-4.775903,"twenty":-9.141718,"median":-7.263319,"eighty":-5.121191,"marketCap":12431676},{"date":"2025-04-25","current":-5.470376,"twenty":-9.018804,"median":-7.217821,"eighty":-5.172643,"marketCap":14239390},{"date":"2025-05-02","current":-5.034285,"twenty":-8.912535,"median":-7.170953,"eighty":-5.172643,"marketCap":13104245},{"date":"2025-05-09","current":-4.841892,"twenty":-8.744808,"median":-7.124084,"eighty":-5.140524,"marketCap":12603446},{"date":"2025-05-16","current":-2.898471,"twenty":-8.706398,"median":-7.030345,"eighty":-5.053706,"marketCap":10266383},{"date":"2025-05-23","current":-2.643971,"twenty":-8.706398,"median":-7.030345,"eighty":-4.968305,"marketCap":9364944},{"date":"2025-05-30","current":-2.626341,"twenty":-8.693594,"median":-6.936607,"eighty":-4.902727,"marketCap":9302501},{"date":"2025-06-06","current":-2.390394,"twenty":-8.64238,"median":-6.865004,"eighty":-4.843183,"marketCap":8466776},{"date":"2025-06-13","current":-2.711492,"twenty":-8.629576,"median":-6.796001,"eighty":-4.780395,"marketCap":9604104},{"date":"2025-06-20","current":-2.911286,"twenty":-8.578362,"median":-6.702263,"eighty":-4.758377,"marketCap":10311775},{"date":"2025-06-27","current":-3.282332,"twenty":-8.578362,"median":-6.467918,"eighty":-4.698397,"marketCap":11626021},{"date":"2025-07-03","current":-3.096809,"twenty":-8.578362,"median":-6.421049,"eighty":-4.598431,"marketCap":10968898},{"date":"2025-07-11","current":-3.382229,"twenty":-8.578362,"median":-6.327311,"eighty":-4.315248,"marketCap":11979856},{"date":"2025-07-18","current":-4.852143,"twenty":-8.578362,"median":-6.210138,"eighty":-4.078861,"marketCap":17186292},{"date":"2025-07-25","current":-4.424013,"twenty":-8.501541,"median":-6.156578,"eighty":-4.315248,"marketCap":15669854},{"date":"2025-08-01","current":-4.281779,"twenty":-8.456729,"median":-5.830571,"eighty":-4.144691,"marketCap":15166060},{"date":"2025-08-08","current":-4.566723,"twenty":-8.326712,"median":-5.698056,"eighty":-4.256377,"marketCap":16175333},{"date":"2025-08-15","current":-5.460044,"twenty":-8.265781,"median":-5.577408,"eighty":-4.144691,"marketCap":25722268},{"date":"2025-08-22","current":-5.151816,"twenty":-8.175816,"median":-5.56016,"eighty":-4.256377,"marketCap":24270205},{"date":"2025-08-29","current":-5.548109,"twenty":-8.117706,"median":-5.504045,"eighty":-4.350727,"marketCap":26137143},{"date":"2025-09-05","current":-6.825055,"twenty":-8.080211,"median":-5.554134,"eighty":-4.371339,"marketCap":32152835},{"date":"2025-09-12","current":-7.925871,"twenty":-8.146034,"median":-5.577408,"eighty":-4.403843,"marketCap":37338777},{"date":"2025-09-19","current":-5.90037,"twenty":-8.123413,"median":-5.684601,"eighty":-4.424013,"marketCap":27796645},{"date":"2025-09-26","current":-5.019718,"twenty":-8.080211,"median":-5.577408,"eighty":-4.452555,"marketCap":23647892},{"date":"2025-10-03","current":-5.063751,"twenty":-8.031527,"median":-5.554134,"eighty":-4.485854,"marketCap":23855329},{"date":"2025-10-10","current":-5.812305,"twenty":-7.985263,"median":-5.56016,"eighty":-4.525921,"marketCap":27381769},{"date":"2025-10-17","current":-5.151816,"twenty":-7.967725,"median":-5.531688,"eighty":-4.55855,"marketCap":24270205},{"date":"2025-10-24","current":-4.799555,"twenty":-7.967725,"median":-5.492822,"eighty":-4.58125,"marketCap":22610703},{"date":"2025-10-31","current":-5.019718,"twenty":-7.967725,"median":-5.46521,"eighty":-4.595432,"marketCap":23647892},{"date":"2025-11-07","current":-3.830837,"twenty":-7.967725,"median":-5.399832,"eighty":-4.525921,"marketCap":18047075},{"date":"2025-11-14","current":-3.48298,"twenty":-7.942613,"median":-5.371979,"eighty":-4.424013,"marketCap":16408318},{"date":"2025-11-21","current":-2.82458,"twenty":-7.922862,"median":-5.327946,"eighty":-4.230974,"marketCap":14298023},{"date":"2025-11-28","current":-3.42923,"twenty":-7.902108,"median":-5.296194,"eighty":-4.097795,"marketCap":17358761},{"date":"2025-12-05","current":-3.740193,"twenty":-7.855239,"median":-5.283914,"eighty":-3.903739,"marketCap":18932856},{"date":"2025-12-12","current":-3.331745,"twenty":-7.817744,"median":-5.203591,"eighty":-3.780288,"marketCap":16865295},{"date":"2025-12-19","current":-3.187781,"twenty":-7.79431,"median":-5.197038,"eighty":-3.655562,"marketCap":16136548},{"date":"2025-12-26","current":-3.052866,"twenty":-7.780249,"median":-5.190491,"eighty":-3.531486,"marketCap":15453608},{"date":"2026-01-02","current":-2.920419,"twenty":-7.780249,"median":-5.153702,"eighty":-3.48298,"marketCap":14783160},{"date":"2026-01-09","current":-3.989868,"twenty":-7.780249,"median":-5.151816,"eighty":-3.42923,"marketCap":20196712},{"date":"2026-01-16","current":-3.660807,"twenty":-7.780249,"median":-5.14469,"eighty":-3.42923,"marketCap":18531004},{"date":"2026-01-23","current":-3.208347,"twenty":-7.755842,"median":-5.119133,"eighty":-3.42923,"marketCap":16240655},{"date":"2026-01-30","current":-2.734499,"twenty":-7.661662,"median":-5.098261,"eighty":-3.381278,"marketCap":13842035},{"date":"2026-02-06","current":-2.426827,"twenty":-7.586816,"median":-5.063751,"eighty":-3.364521,"marketCap":12284598},{"date":"2026-02-13","current":-2.442869,"twenty":-7.51395,"median":-5.063751,"eighty":-3.27767,"marketCap":12365801},{"date":"2026-02-20","current":-2.303429,"twenty":-7.470914,"median":-5.048278,"eighty":-3.204892,"marketCap":11659957},{"date":"2026-02-27","current":-2.271757,"twenty":-7.452166,"median":-5.027001,"eighty":-3.156747,"marketCap":11499633},{"date":"2026-03-06","current":-2.698302,"twenty":-7.424045,"median":-5.019718,"eighty":-3.093003,"marketCap":13658807}],"updateTime":1773125992711},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KAPA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1180765105","title":"Kairos Pharma簽署具有約束力的戰略資產收購協議，獲得Orbimed及Torrey Pines投資支持的Celyn Therapeutics旗下Cl-273全球獨家授權","url":"https://stock-news.laohu8.com/highlight/detail?id=1180765105","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180765105?lang=zh_tw&edition=fundamental","pubTime":"2026-03-02 19:30","pubTimestamp":1772451016,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. (简称：Kairos Pharma) 正式宣布，已签署一项具有约束力的战略资产收购协议。根据协议，Kairos Pharma将获得来自Orbimed及Torrey Pines投资支持的Celyn Therapeutics所持有的Cl-273项目的全球独家权利。\n此次收购标志着Kairos Pharma在拓展其产品管线方面迈出关键一步，进一步巩固了公司在创新疗法领域的战略布局。Cl-273作为一项具有潜力的候选药物，其全球独家权利的获取将为公司未来业务增长注入新动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2614020606","title":"Kairos Pharma, Ltd.股價上漲13.85% 市值漲206.42萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614020606","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614020606?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 22:31","pubTimestamp":1772116291,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时31分，Kairos Pharma, Ltd.股票出现波动，股价快速拉升13.85%。Kairos Pharma, Ltd.股票所在的生物技术行业中，整体跌幅为0.94%。其相关个股中，Curanex Pharmaceuticals Inc、Liminatus Pharma Inc C/Wts 30/04/2030 、Psyence Biomedical Ltd C/Wts 25/01/2029涨幅较大，Curanex Pharmaceuticals Inc、Kairos Pharma, Ltd.、Edesa Biotech, Inc.较为活跃，换手率分别为152.34%、82.55%、22.86%，振幅较大的相关个股有Edesa Biotech, Inc.、Curanex Pharmaceuticals Inc、Moolec Science Sa C/Wts 30/01/2028，振幅分别为10.29%、9.35%、9.27%。Kairos Pharma, Ltd.公司简介：Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223131a4cbf589&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223131a4cbf589&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","BK4139","KAIR"],"gpt_icon":0},{"id":"2614008551","title":"Uniqure N.V.股價重挫16.96% 市值漲5422.18萬美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2614008551","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614008551?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 22:30","pubTimestamp":1772116209,"startTime":"0","endTime":"0","summary":"北京时间2026年02月26日22时30分，Uniqure N.V.股票出现异动，股价大幅跳水16.96%。截至发稿，该股报20.65美元/股，成交量202.299万股，换手率3.25%，振幅8.78%。Uniqure N.V.股票所在的生物技术行业中，整体涨幅为0.00%。Uniqure N.V.公司简介：uniQure NV 是一家基因治疗公司。该公司专注于与 Bristol Myers Squibb 合作开发用于心血管疾病的基因疗法。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260226223010a722dad7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["QURE","KAPA","LU0109394709.USD","BK4139","LU0320765992.SGD","LU0889565916.HKD"],"gpt_icon":0},{"id":"1157906189","title":"Kairos製藥有限公司簽署條款書，擬戰略性收購Celyn Therapeutics兩項臨床腫瘤資產","url":"https://stock-news.laohu8.com/highlight/detail?id=1157906189","media":"美股速递","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1157906189?lang=zh_tw&edition=fundamental","pubTime":"2026-02-26 20:02","pubTimestamp":1772107360,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd. 已与Celyn Therapeutics达成协议，签署了一份关于战略性资产收购的条款书。根据该条款书，Kairos将收购Celyn Therapeutics旗下的两项临床阶段肿瘤治疗资产。这一举措标志着Kairos在拓展其肿瘤治疗产品线方面迈出了重要一步，有望进一步增强公司在临床肿瘤领域的研发实力和市场竞争力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"2601812646","title":"Kairos Pharma, Ltd.盤中異動 快速上漲5.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601812646","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601812646?lang=zh_tw&edition=fundamental","pubTime":"2026-01-07 00:04","pubTimestamp":1767715478,"startTime":"0","endTime":"0","summary":"北京时间2026年01月07日00时04分，Kairos Pharma, Ltd.股票出现波动，股价快速拉升5.41%。Kairos Pharma, Ltd.股票所在的生物技术行业中，整体涨幅为0.83%。其相关个股中，Alumis Inc.、Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 涨幅较大，Pmgc Holdings Inc.、Cyclerion Therapeutics, Inc.、Transcode Therapeutics, Inc.较为活跃，换手率分别为2025.86%、1551.74%、232.00%，振幅较大的相关个股有Seastar Medical Holding Corp C/Wts 28/10/2027 、Lexaria Bioscience Corp C/Wts 14/01/2026 、Alumis Inc.，振幅分别为294.74%、161.40%、71.00%。Kairos Pharma, Ltd.公司简介：Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107000439a4a41284&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260107000439a4a41284&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","KAPA","KAIR"],"gpt_icon":0},{"id":"2582313405","title":"Kairos Pharma, Ltd.盤中異動 早盤股價大跌5.06%報0.881美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2582313405","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582313405?lang=zh_tw&edition=fundamental","pubTime":"2025-11-11 22:43","pubTimestamp":1762872230,"startTime":"0","endTime":"0","summary":"北京时间2025年11月11日22时43分，Kairos Pharma, Ltd.股票出现异动，股价大幅跳水5.06%。截至发稿，该股报0.881美元/股，成交量2595股，换手率0.01%，振幅0.00%。Kairos Pharma, Ltd.股票所在的生物技术行业中，整体涨幅为0.18%。Kairos Pharma, Ltd.公司简介：Kairos Pharma Ltd 是一家处于临床阶段的生物制药公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112243509762b5dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202511112243509762b5dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["KAPA","KAIR","BK4139"],"gpt_icon":0},{"id":"1109723454","title":"Kairos Pharma將在2025年ESMO大會上公布前列腺癌二期試驗積極的安全性和療效數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1109723454","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109723454?lang=zh_tw&edition=fundamental","pubTime":"2025-10-07 20:02","pubTimestamp":1759838561,"startTime":"0","endTime":"0","summary":"Kairos Pharma将在2025年ESMO大会上展示其前列腺癌二期临床试验取得的积极安全性和疗效数据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"gpt_icon":0},{"id":"1152471483","title":"Kairos Pharma宣佈Env105治療晚期前列腺癌2期試驗積極中期療效分析結果，中位無進展生存期超過一年","url":"https://stock-news.laohu8.com/highlight/detail?id=1152471483","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152471483?lang=zh_tw&edition=fundamental","pubTime":"2025-09-18 20:04","pubTimestamp":1758197053,"startTime":"0","endTime":"0","summary":"Kairos Pharma宣布其药物Env105治疗晚期前列腺癌的2期临床试验取得积极的中期疗效分析结果，患者中位无进展生存期超过一年。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["KAPA","BK4139"],"gpt_icon":0},{"id":"1105900764","title":"Kairos Pharma, Ltd.宣佈舉辦虛擬專家活動 分享Env105治療晚期前列腺癌中期療效數據見解","url":"https://stock-news.laohu8.com/highlight/detail?id=1105900764","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1105900764?lang=zh_tw&edition=fundamental","pubTime":"2025-09-11 20:00","pubTimestamp":1757592053,"startTime":"0","endTime":"0","summary":"Kairos Pharma, Ltd.宣布将举办虚拟专家活动，邀请行业意见领袖分享对其候选药物Env105在晚期前列腺癌治疗中期疗效结果的专业见解和观点。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","KAPA"],"gpt_icon":0}],"pageSize":20,"totalPage":1,"pageCount":1,"totalSize":9,"code":"91000000","status":"200"}]}}